{
    "title": "105_hr1398",
    "content": "The \"Parkinson's Research Act of 1997\" aims to expand federal investment in Parkinson's research and improve coordination among NIH institutes. It also seeks to enhance care and assistance for individuals with Parkinson's and their family caregivers. The \"Parkinson's Research Act of 1997\" expands federal investment in Parkinson's research under the Public Health Service Act. The \"Parkinson's Research Act of 1997\" expands federal investment in Parkinson's research under the Public Health Service Act. Sec. 409B establishes a program for research and training on Parkinson's disease, with coordination among national research institutes and regular research planning conferences. The \"Parkinson's Research Act of 1997\" mandates conferences to report to specific committees on Parkinson's research. The Director of NIH will award Core Center Grants for innovative research and training on Parkinson's, limited to 10 grants. The Director will award up to 10 Core Center Grants for Parkinson's research, designating each center as a Morris K. Udall Center. Centers must meet qualifications set by the NIH Director and use facilities of a single institution or consortium. The Director of the NIH may prescribe requirements for Parkinson's research centers to conduct basic and clinical research, training programs, and education initiatives for health professionals. The NIH may require Parkinson's research centers to conduct programs for disseminating information to the public, establish a nationwide data system, and create a Parkinson's Disease Information Clearinghouse. The NIH may require Parkinson's research centers to establish a national education program and provide stipends for scientists and health professionals in training programs. The NIH may support Parkinson's research centers for up to five years, with possible extensions for additional five-year periods after review by a peer group. Additionally, the Director of NIH will establish a grant program for excellence in Parkinson's Disease research. The Director of NIH will establish a grant program to support excellence in Parkinson's research, with grants available for up to 5 years. $100,000,000 is authorized for fiscal year 1998, with additional funding for 1999 and 2000. The Act authorizes funding for Parkinson's research for fiscal years 1999 and 2000, with a limitation on the use of funds for research involving human fetal tissue obtained from embryos or fetuses during or after induced abortions, except in cases of spontaneous abortion or ectopic pregnancy."
}